IL-35 injections show promise as type 1 diabetes treatment
30 July 2015 | By Victoria White
Administration of IL-35 to mice with type 1 diabetes reverses or cures the disease by maintaining a normal blood glucose level and immune tolerance...
List view / Grid view
News
Inovio’s DNA-based monoclonal antibody (dMAb) protects against dengue
30 July 2015 | By Victoria White
Inovio’s DNA-based monoclonal antibody (dMAb) targeting dengue virus provided protection against a lethal dengue virus challenge in mice...
Sygnature Discovery delivers clinical candidate CORT125134 to Corcept
30 July 2015 | By Victoria White
Sygnature Discovery has delivered CORT125134, a glucocorticoid receptor antagonist in development for the treatment of Cushing’s syndrome, to Corcept...
Scientists successfully edit human T cells using CRISPR
29 July 2015 | By Victoria White
Scientists have precisely modifed human T cells using the CRISPR genome-editing system- a breakthrough that could lead to CRISPR/Cas9-based therapies...
Cystic fibrosis microbes able to survive on little to no oxygen
29 July 2015 | By Victoria White
CF microbes are able to survive in saliva and mucus that is chemically heterogeneous, including significant portions that are largely devoid of oxygen...
Experimental MERS vaccine shows promise in animal studies
29 July 2015 | By Victoria White
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques...
Basis for new treatment options for a fatal leukaemia revealed
29 July 2015 | By Victoria White
An international team of scientists have succeeded in decoding the molecular characteristics of an as yet incurable subtype of leukaemia...
Researchers discover new type of mycovirus
28 July 2015 | By Victoria White
Researchers have discovered a completely new type of mycovirus that can infect the fungus Aspergillus fumigatus, which can cause the disease aspergillosis
UMG and MRC Technology collaborate to develop Alzheimer’s therapy
28 July 2015 | By Victoria White
UMG and MRC Technology are to collaborate to develop a novel therapy for neurodegenerative diseases based on antibody targeting amyloid beta peptides 4-x...
Scientists discover exercise mimicking molecule ‘compound 14’
28 July 2015 | By Victoria White
Scientists have developed a molecule, called 'compound 14', that acts as an exercise mimic, which could potentially help treat type 2 diabetes and obesity...
Regeneron and Sanofi launch major immuno-oncology collaboration
28 July 2015 | By Victoria White
Regeneron and Sanofi have entered into a new global collaboration to discover, develop and commercialise new antibody cancer treatments in immuno-oncology...
Biogen sparks up strategic alliance with the Parkinson’s Institute and Clinical Centre
27 July 2015 | By Victoria White
Biogen and the Parkinson’s Institute have entered a strategic alliance focused on enhancing the understanding of the underlying biology of Parkinson’s...
Protein RGS2 helps prepare for healthy egg-sperm union
27 July 2015 | By Victoria White
Researchers have discovered RGS2, a protein being looked at as a target for hypertension and heart ailments, plays a vital role in healthy egg-sperm union...
Cancer can be caused by protein imbalances within cells
27 July 2015 | By Victoria White
Genetic aberrations have been seen as the main cause of almost all cancer but new research shows cancer can be caused solely by protein imbalances...
Six major projects to bring molecular pathology tests to patients
27 July 2015 | By Victoria White
The MRC and EPSRC have made a joint award of £16m to develop molecular pathology tests to help deliver stratified medicine in a wide range of disease areas...